tetradecanoylphorbol acetate has been researched along with gsk-j4 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, H; Kim, JY; Oh, H; Park, JW; Seo, SB | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and gsk-j4
Article | Year |
---|---|
AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway.
Topics: Aurora Kinase A; Azepines; Benzazepines; Cell Differentiation; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation, Leukemic; Genes, Reporter; HEK293 Cells; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Leukemia, Monocytic, Acute; Monocytes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Oncogene Proteins, Fusion; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Pyrimidines; Recombinant Proteins; RNA Interference; RNA, Small Interfering; Tetradecanoylphorbol Acetate; THP-1 Cells; YY1 Transcription Factor | 2018 |